Today, CSafe is expanding its passive packaging portfolio with the launch of the new AcuTemp Plus Series to address the coldchain needs of commercial pharma, clinical trials and cell and gene therapies. With high-performing vacuum insulated panels and single temperature phase change material, this enhanced series is optimally designed for performance, simplicity and efficiency.
“The AcuTemp Plus Series has been developed with our customers in mind, offering them the level of performance and quality they expect, while delivering the peace of mind they deserve,” stated Patrick Schafer, CEO of CSafe Global. “The new AcuTemp Plus Series represents a new era in reusable VIP passive packaging, providing an end-to-end coldchain solution with an industry-leading level of temperature performance.”